Investors Seek GLP-1 Alternatives After Nausea Hurdles
A new wave of weight-loss therapies aims to beat current GLP-1 drugs by reducing side effects and daily dosing. Inves...
Learn where to look for investment opportunities that can lead to substantial financial growth. Discover places to start your search.
21,370 articlesA new wave of weight-loss therapies aims to beat current GLP-1 drugs by reducing side effects and daily dosing. Inves...
When a daughter tried sell mother’s assets, a routine real estate conversation uncovered a troubling pattern of elder...
Anthropic’s Claude Code is reshaping cost math for developers and businesses. The man behind the tool argues ROI shou...
Anthropic unveils Claude Mythos in a full cybersecurity-focused release, paired with a safer Fable 5 for general user...
A single Magnificent 7 stock is proving steadier than peers as AI demand drives earnings and share gains, challenging...
As lawmakers grapple with federal spending, fresh numbers show social security benefits costs are manageable today, a...
Oil sits near $90 per barrel on June 12, 2026, with Brent guiding the market. Traders weigh supply discipline, demand...
A routine filming day turned into a medical emergency, reminding all of us that health costs can hit hard. This guide...
SpaceX opened its public life with a 19% first-day jump, valuing the company at more than $2 trillion. The boom shine...
XRP surged more than 13% in 24 hours, reclaiming the $1.28 level as sentiment improves and buyers return. On-chain da...
Two aviation ETFs pull in opposite directions: JETS targets airlines and airports, ITA leans into defense and aerospa...
Two big market events could move stocks this month. Learn how a Federal Reserve decision and the latest inflation and...